Institute of Biomedical Sciences assistant research fellow Dr. Kurt Yun Mou\u2019s team developed a novel cancer therapy and published their results in \u201cMolecular Therapy\u201d in April this year. The research group develop a Trojan Horse approach to target TNF-\u03b1 for cancer therapy. They employed phage\/yeast display to select non-neutralizing antibodies that can piggyback on TNF-\u03b1 and co-internalize into cells. The antibody conjugated with toxins killed cancer cells in a TNF-\u03b1-dependent manner. Intratumoral injection of engineered E. coli<\/em> secreting the immunotoxin greatly inhibited the tumor growth in mice and enhanced the anti-tumor tumor-infiltrating immune cells, including N1 neutrophils, M1 macrophages, and activated CD4+ and CD8+ lymphocytes. The results were published in Molecular Therapy<\/em>.<\/p>\n
Article Link: https:\/\/www.cell.com\/molecular-therapy-family\/molecular-therapy\/fulltext\/S1525-0016(22)00237-4<\/a><\/p>\n